DV
Dividend Vision

SLP — Simulations Plus Inc

Simulations Plus Inc (SLP)

Total return is 1611.3% over the past 29.2 years, 274.5 points ahead of SPY at 1336.8%. Its deepest 1-year drawdown was 45.5%.

Simulations Plus develops drug discovery and development software that uses artificial intelligence and machine learning to model molecular properties and predict drug behavior in humans and animals. The company serves pharmaceutical, biotechnology, and other life sciences companies through its software products—including GastroPlus, DDDPlus, and ADMET Predictor—and related consulting services. The stock does not currently distribute dividends, making it suited primarily to growth-oriented investors rather than those seeking current income.

SLP key facts

Asset type
Stock
Asset class
Equity
Inception date
06/18/1997
Distribution frequency
Quarterly
5-year average yield
0.52
Last close
$18.35
Market cap
$368,294,272
Average volume
214600.0
Ex-dividend date
07/29/2024
Payment date
08/05/2024
Beta
1.306
Payout ratio
0.0
P/E ratio
45.525
Forward P/E
21.645
EPS
$0.40